2,5-Diethyl-4-methylthiazole
Common Name: |
2,5-Diethyl-4-methylthiazole |
IUPAC Name: |
2,5-diethyl-4-methyl-1,3-thiazole |
Molecular Formula: |
C6H8OS |
SMILES: |
CCC1=C(N=C(S1)CC)C |
Inchi: |
1S/C8H13NS/c1-4-7-6(3)9-8(5-2)10-7/h4-5H2,1-3H3 |
Inchi Key: |
AEVBKBWVXISVBJ-UHFFFAOYSA-N |
Cas No: |
41981-71-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
128.19 |
Mass (g/mol) |
155.077 |
Molar Refractivity |
36.07 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
38.44 |
Hetero Atoms |
2 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
5 |
Melting Point (°C) |
115.00 |
Boiling Point (°C@760.00mm Hg) |
217.00 to 218.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.191 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.33 |
LogP |
2.576 |
iLOGP |
1.83 |
XLOGP3 |
1.61 |
WLOGP |
1.99 |
MLOGP |
0.84 |
ESOL Log S |
-1.98 |
ESOL Solubility (mg/ml) |
1.34 |
ESOL Solubility (mol/l) |
0.011 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.03 |
Ali Solubility (mg/ml) |
1.2 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.47 |
Silicos-IT Solubility (mg/ml) |
0.43 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.94 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.823 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.057 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |